vs
MIMEDX GROUP, INC.（MDXG）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是MIMEDX GROUP, INC.的1.4倍（$162.6M vs $118.1M），Ribbon Communications Inc.净利率更高（54.8% vs 12.9%，领先41.9%），MIMEDX GROUP, INC.同比增速更快（27.1% vs -10.3%），过去两年MIMEDX GROUP, INC.的营收复合增速更高（18.1% vs -8.1%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
MDXG vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.4倍
$118.1M
营收增速更快
MDXG
高出37.4%
-10.3%
净利率更高
RBBN
高出41.9%
12.9%
两年增速更快
MDXG
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $162.6M |
| 净利润 | $15.2M | $89.1M |
| 毛利率 | 83.9% | 42.9% |
| 营业利润率 | 17.8% | 37.6% |
| 净利率 | 12.9% | 54.8% |
| 营收同比 | 27.1% | -10.3% |
| 净利润同比 | 104.2% | — |
| 每股收益（稀释后） | $0.10 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $118.1M | $227.3M | ||
| Q3 25 | $113.7M | $215.4M | ||
| Q2 25 | $98.6M | $220.6M | ||
| Q1 25 | $88.2M | $181.3M | ||
| Q4 24 | $92.9M | $251.4M | ||
| Q3 24 | $84.1M | $210.2M | ||
| Q2 24 | $87.2M | $192.6M |
净利润MDXGRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $15.2M | — | ||
| Q3 25 | $16.7M | $-12.1M | ||
| Q2 25 | $9.6M | $-11.1M | ||
| Q1 25 | $7.0M | $-26.2M | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $8.1M | $-13.4M | ||
| Q2 24 | $17.6M | $-16.8M |
毛利率MDXGRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | 83.9% | 53.3% | ||
| Q3 25 | 83.5% | 50.1% | ||
| Q2 25 | 81.1% | 49.6% | ||
| Q1 25 | 81.2% | 45.4% | ||
| Q4 24 | 81.8% | 55.7% | ||
| Q3 24 | 81.8% | 52.1% | ||
| Q2 24 | 83.0% | 50.8% |
营业利润率MDXGRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 17.8% | 4.1% | ||
| Q3 25 | 19.5% | 1.3% | ||
| Q2 25 | 12.5% | 1.9% | ||
| Q1 25 | 9.4% | -10.8% | ||
| Q4 24 | 11.9% | 13.2% | ||
| Q3 24 | 13.3% | -0.4% | ||
| Q2 24 | 26.9% | -1.0% |
净利率MDXGRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | 12.9% | — | ||
| Q3 25 | 14.7% | -5.6% | ||
| Q2 25 | 9.8% | -5.0% | ||
| Q1 25 | 8.0% | -14.5% | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | -6.4% | ||
| Q2 24 | 20.2% | -8.7% |
每股收益（稀释后）MDXGRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.10 | $0.50 | ||
| Q3 25 | $0.11 | $-0.07 | ||
| Q2 25 | $0.06 | $-0.06 | ||
| Q1 25 | $0.05 | $-0.15 | ||
| Q4 24 | $0.05 | $0.05 | ||
| Q3 24 | $0.05 | $-0.08 | ||
| Q2 24 | $0.12 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $67.6M |
| 总债务越低越好 | $18.0M | — |
| 股东权益账面价值 | $256.5M | $419.1M |
| 总资产 | $342.7M | — |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资MDXGRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $166.1M | $96.4M | ||
| Q3 25 | $142.1M | $74.8M | ||
| Q2 25 | $118.9M | $60.5M | ||
| Q1 25 | $106.4M | $71.2M | ||
| Q4 24 | $104.4M | $87.8M | ||
| Q3 24 | $88.8M | $37.2M | ||
| Q2 24 | $69.0M | $64.6M |
总债务MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | $18.0M | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | $19.0M | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益MDXGRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $256.5M | $449.0M | ||
| Q3 25 | $238.9M | $360.1M | ||
| Q2 25 | $216.6M | $370.4M | ||
| Q1 25 | $202.8M | $381.8M | ||
| Q4 24 | $193.1M | $404.6M | ||
| Q3 24 | $181.0M | $395.5M | ||
| Q2 24 | $168.0M | $405.0M |
总资产MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | $342.7M | $1.2B | ||
| Q3 25 | $319.0M | $1.1B | ||
| Q2 25 | $291.1M | $1.1B | ||
| Q1 25 | $270.4M | $1.1B | ||
| Q4 24 | $263.9M | $1.2B | ||
| Q3 24 | $243.9M | $1.1B | ||
| Q2 24 | $230.2M | $1.1B |
负债/权益比MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.07× | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | 0.10× | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | $25.0M | $29.2M | ||
| Q3 25 | $29.3M | $26.5M | ||
| Q2 25 | $14.4M | $-795.0K | ||
| Q1 25 | $5.3M | $-3.5M | ||
| Q4 24 | $18.8M | $61.8M | ||
| Q3 24 | $19.6M | $-14.8M | ||
| Q2 24 | $21.8M | $-9.8M |
自由现金流MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $21.0M | ||
| Q2 25 | — | $-6.5M | ||
| Q1 25 | — | $-15.7M | ||
| Q4 24 | — | $53.8M | ||
| Q3 24 | — | $-23.7M | ||
| Q2 24 | — | $-12.9M |
自由现金流率MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | — | -2.9% | ||
| Q1 25 | — | -8.7% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -6.7% |
资本支出强度MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 1.6% |
现金转化率MDXGRBBN
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | 1.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
